Dolutegravir / Abacavir / Lamivudine

Also known as Triumeq (us)

HIV & PrEP

Infections

Save $3,644/mo

59× cheaper

The combination of abacavir, dolutegravir, and lamivudine is used to treat HIV infection.

United States

$3,707

per month

India

$63

per month

You save

$3,644

98% cheaper in India

143.2K US scripts/yr$521.7M potential annual savings$530.7M US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$3,707per month

India price$63per month

You save$3,64498% less

Based on 30 units per month. US $123.56 vs India $2.09 per unit.

How many months / courses?

Total over 1 periodSave $3,644$3,707 → $63

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $21,864
Estimated travel cost: − $2,300
Net savings after travel: $19,564

Even after travel, you could come out ahead by about $19,564.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Dolutegravir / Abacavir / Lamivudine is filled about 143.2K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$530.7M

If sourced from India

$9M

Potential annual savings

$521.7M

−98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.